Symbol:
Mocos
Name:
molybdenum cofactor sulfurase
RGD ID:
1308496
Description:
Predicted to enable molybdenum cofactor sulfurtransferase activity. Predicted to be involved in molybdopterin cofactor biosynthetic process. Human ortholog(s) of this gene implicated in xanthinuria type II. Orthologous to human MOCOS (molybdenum cofactor sulfurase); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3-chloropropane-1,2-diol; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC361300
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 18 16,206,402 - 16,251,928 (+) NCBI GRCr8 mRatBN7.2 18 15,931,659 - 15,977,415 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 18 15,931,654 - 15,977,187 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 18 16,117,319 - 16,162,950 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 18 16,900,026 - 16,945,653 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 18 16,188,313 - 16,233,744 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 18 16,590,086 - 16,636,312 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 18 16,590,197 - 16,636,084 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 18 16,349,169 - 16,395,056 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 18 16,420,503 - 16,466,040 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 18 16,447,589 - 16,492,609 (+) NCBI Celera 18 15,859,448 - 15,904,747 (+) NCBI Celera Cytogenetic Map 18 p12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Mocos Rat (+)-catechin multiple interactions ISO RGD:1318297 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MOCOS mRNA CTD PMID:24763279 Mocos Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318297 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MOCOS mRNA CTD PMID:22079256 Mocos Rat (1->4)-beta-D-glucan multiple interactions ISO RGD:1616767 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MOCOS mRNA CTD PMID:36331819 Mocos Rat 1,2-dimethylhydrazine decreases expression ISO RGD:1616767 6480464 1,2-Dimethylhydrazine results in decreased expression of MOCOS mRNA CTD PMID:22206623 Mocos Rat 1-nitropyrene increases expression ISO RGD:1318297 6480464 1-nitropyrene results in increased expression of MOCOS mRNA CTD PMID:19041380 Mocos Rat 17alpha-ethynylestradiol increases expression ISO RGD:1616767 6480464 Ethinyl Estradiol results in increased expression of MOCOS mRNA CTD PMID:17942748 Mocos Rat 17beta-estradiol multiple interactions ISO RGD:1318297 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MOCOS mRNA CTD PMID:30165855 Mocos Rat 17beta-estradiol increases expression ISO RGD:1318297 6480464 Estradiol results in increased expression of MOCOS mRNA CTD PMID:31614463 Mocos Rat 17beta-estradiol increases expression ISO RGD:1616767 6480464 Estradiol results in increased expression of MOCOS mRNA CTD PMID:39298647 Mocos Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1616767 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of MOCOS mRNA CTD PMID:16214954 Mocos Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318297 6480464 Tetrachlorodibenzodioxin results in increased expression of MOCOS mRNA CTD PMID:20106945|PMID:21632981|PMID:26238291 Mocos Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1616767 6480464 Tetrachlorodibenzodioxin affects the expression of MOCOS mRNA CTD PMID:21570461 Mocos Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MOCOS mRNA CTD PMID:21215274 Mocos Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1616767 6480464 Tetrachlorodibenzodioxin results in increased expression of MOCOS mRNA CTD PMID:18796159|PMID:28922406 Mocos Rat 3,7-dihydropurine-6-thione multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis more ... CTD PMID:29935280 Mocos Rat 3,7-dihydropurine-6-thione decreases oxidation ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased oxidation of Mercaptopurine CTD PMID:29935280 Mocos Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of MOCOS protein CTD PMID:34915118 Mocos Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1616767 6480464 bisphenol S results in increased expression of MOCOS mRNA CTD PMID:39298647 Mocos Rat 4-hydroxynon-2-enal increases expression ISO RGD:1616767 6480464 4-hydroxy-2-nonenal results in increased expression of MOCOS mRNA CTD PMID:19191707 Mocos Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MOCOS mRNA CTD PMID:24780913 Mocos Rat 6-Thiourate multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis more ... CTD PMID:29935280 Mocos Rat 8-Br-cAMP increases expression ISO RGD:1318297 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MOCOS mRNA CTD PMID:22079614 Mocos Rat amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of MOCOS mRNA CTD PMID:30779732 Mocos Rat arsane multiple interactions ISO RGD:1318297 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MOCOS more ... CTD PMID:39836092 Mocos Rat arsenic atom multiple interactions ISO RGD:1318297 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MOCOS more ... CTD PMID:39836092 Mocos Rat arsenite(3-) multiple interactions ISO RGD:1318297 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MOCOS mRNA] CTD PMID:32406909 Mocos Rat arsenous acid increases expression ISO RGD:1318297 6480464 Arsenic Trioxide results in increased expression of MOCOS mRNA CTD PMID:20458559 Mocos Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MOCOS gene CTD PMID:28931070 Mocos Rat azathioprine multiple interactions ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased metabolism of and affects the susceptibility to Azathioprine CTD PMID:29935280 Mocos Rat benzo[a]pyrene increases expression ISO RGD:1616767 6480464 Benzo(a)pyrene results in increased expression of MOCOS mRNA CTD PMID:19770486|PMID:21569818|PMID:22228805 Mocos Rat benzo[a]pyrene increases methylation ISO RGD:1318297 6480464 Benzo(a)pyrene results in increased methylation of MOCOS promoter CTD PMID:27901495 Mocos Rat benzo[a]pyrene increases expression ISO RGD:1318297 6480464 Benzo(a)pyrene results in increased expression of MOCOS mRNA CTD PMID:22316170|PMID:26238291 Mocos Rat Benzo[k]fluoranthene decreases expression ISO RGD:1616767 6480464 benzo(k)fluoranthene results in decreased expression of MOCOS mRNA CTD PMID:26377693 Mocos Rat bisphenol A decreases expression ISO RGD:1616767 6480464 bisphenol A results in decreased expression of MOCOS mRNA CTD PMID:23798566 Mocos Rat bisphenol A decreases expression ISO RGD:1318297 6480464 bisphenol A results in decreased expression of MOCOS protein CTD PMID:33376534 Mocos Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MOCOS mRNA CTD PMID:32145629|PMID:34947998 Mocos Rat bisphenol A increases expression ISO RGD:1616767 6480464 bisphenol A results in increased expression of MOCOS mRNA CTD PMID:34585602 Mocos Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MOCOS mRNA CTD PMID:30816183|PMID:32528016 Mocos Rat bisphenol A increases expression ISO RGD:1318297 6480464 bisphenol A results in increased expression of MOCOS mRNA CTD PMID:29275510 Mocos Rat bisphenol A affects expression ISO RGD:1318297 6480464 bisphenol A affects the expression of MOCOS mRNA CTD PMID:30903817 Mocos Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MOCOS mRNA CTD PMID:25181051 Mocos Rat bisphenol F increases expression ISO RGD:1616767 6480464 bisphenol F results in increased expression of MOCOS mRNA CTD PMID:38685157 Mocos Rat bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MOCOS mRNA CTD PMID:32479839 Mocos Rat butan-1-ol multiple interactions ISO RGD:1318297 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... CTD PMID:29432896 Mocos Rat cadmium dichloride decreases expression ISO RGD:1318297 6480464 Cadmium Chloride results in decreased expression of MOCOS mRNA CTD PMID:38568856 Mocos Rat cadmium sulfate increases expression ISO RGD:1616767 6480464 cadmium sulfate results in increased expression of MOCOS mRNA CTD PMID:16221973 Mocos Rat caffeine increases phosphorylation ISO RGD:1318297 6480464 Caffeine results in increased phosphorylation of MOCOS protein CTD PMID:35688186 Mocos Rat carbamazepine affects expression ISO RGD:1318297 6480464 Carbamazepine affects the expression of MOCOS mRNA CTD PMID:25979313 Mocos Rat chromium(6+) affects expression ISO RGD:1318297 6480464 chromium hexavalent ion affects the expression of MOCOS mRNA CTD PMID:30690063 Mocos Rat cisplatin increases expression ISO RGD:1318297 6480464 Cisplatin results in increased expression of MOCOS mRNA CTD PMID:27392435 Mocos Rat cisplatin multiple interactions ISO RGD:1318297 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MOCOS mRNA CTD PMID:27392435 Mocos Rat cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of MOCOS mRNA CTD PMID:24386269 Mocos Rat copper atom multiple interactions ISO RGD:1318297 6480464 [NSC 689534 binds to Copper] which results in increased expression of MOCOS mRNA CTD PMID:20971185 Mocos Rat copper(0) multiple interactions ISO RGD:1318297 6480464 [NSC 689534 binds to Copper] which results in increased expression of MOCOS mRNA CTD PMID:20971185 Mocos Rat copper(II) sulfate increases expression ISO RGD:1318297 6480464 Copper Sulfate results in increased expression of MOCOS mRNA CTD PMID:19549813 Mocos Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MOCOS mRNA CTD PMID:27523638 Mocos Rat cyclosporin A increases expression ISO RGD:1318297 6480464 Cyclosporine results in increased expression of MOCOS mRNA CTD PMID:20106945|PMID:25562108|PMID:27989131 Mocos Rat diarsenic trioxide increases expression ISO RGD:1318297 6480464 Arsenic Trioxide results in increased expression of MOCOS mRNA CTD PMID:20458559 Mocos Rat Didecyldimethylammonium increases expression ISO RGD:1318297 6480464 didecyldimethylammonium results in increased expression of MOCOS mRNA CTD PMID:32763356 Mocos Rat disodium selenite decreases expression ISO RGD:1318297 6480464 Sodium Selenite results in decreased expression of MOCOS mRNA CTD PMID:18175754 Mocos Rat dorsomorphin multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Mocos Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MOCOS mRNA CTD PMID:29391264 Mocos Rat entinostat increases expression ISO RGD:1318297 6480464 entinostat results in increased expression of MOCOS mRNA CTD PMID:26272509 Mocos Rat entinostat multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Mocos Rat epoxiconazole increases expression ISO RGD:1616767 6480464 epoxiconazole results in increased expression of MOCOS mRNA CTD PMID:35436446 Mocos Rat etoposide affects response to substance ISO RGD:1318297 6480464 MOCOS protein affects the susceptibility to Etoposide CTD PMID:16217747 Mocos Rat genistein decreases expression ISO RGD:1616767 6480464 Genistein results in decreased expression of MOCOS mRNA CTD PMID:32186404 Mocos Rat inulin multiple interactions ISO RGD:1616767 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MOCOS mRNA CTD PMID:36331819 Mocos Rat isotretinoin decreases expression ISO RGD:1318297 6480464 Isotretinoin results in decreased expression of MOCOS mRNA CTD PMID:20436886 Mocos Rat lead diacetate increases expression ISO RGD:1616767 6480464 lead acetate results in increased expression of MOCOS mRNA CTD PMID:22609695 Mocos Rat lucanthone decreases expression ISO RGD:1318297 6480464 Lucanthone results in decreased expression of MOCOS mRNA CTD PMID:21148553 Mocos Rat mercaptopurine decreases oxidation ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased oxidation of Mercaptopurine CTD PMID:29935280 Mocos Rat mercaptopurine multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis more ... CTD PMID:29935280 Mocos Rat metformin decreases expression EXP 6480464 Metformin results in decreased expression of MOCOS mRNA CTD PMID:31324951 Mocos Rat mitoxantrone affects response to substance ISO RGD:1318297 6480464 MOCOS protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 Mocos Rat N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1616767 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MOCOS mRNA CTD PMID:20061341|PMID:25566086 Mocos Rat N-methyl-4-phenylpyridinium increases expression ISO RGD:1318297 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MOCOS mRNA CTD PMID:24810058 Mocos Rat paracetamol affects expression ISO RGD:1616767 6480464 Acetaminophen affects the expression of MOCOS mRNA CTD PMID:17562736 Mocos Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MOCOS mRNA CTD PMID:33387578 Mocos Rat pentachlorophenol increases expression ISO RGD:1616767 6480464 Pentachlorophenol results in increased expression of MOCOS mRNA CTD PMID:23892564 Mocos Rat perfluorohexanesulfonic acid increases expression ISO RGD:1318297 6480464 perfluorohexanesulfonic acid results in increased expression of MOCOS mRNA CTD PMID:25812627 Mocos Rat perfluorononanoic acid increases expression ISO RGD:1318297 6480464 perfluoro-n-nonanoic acid results in increased expression of MOCOS mRNA CTD PMID:25812627|PMID:32588087 Mocos Rat perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1616767 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MOCOS mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 Mocos Rat phenylmercury acetate multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Mocos Rat potassium chromate decreases expression ISO RGD:1318297 6480464 potassium chromate(VI) results in decreased expression of MOCOS mRNA CTD PMID:22079256 Mocos Rat potassium chromate increases expression ISO RGD:1318297 6480464 potassium chromate(VI) results in increased expression of MOCOS mRNA CTD PMID:22714537 Mocos Rat potassium chromate multiple interactions ISO RGD:1318297 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MOCOS mRNA CTD PMID:22079256 Mocos Rat purine-6-thiol multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in decreased chemical synthesis more ... CTD PMID:29935280 Mocos Rat purine-6-thiol decreases oxidation ISO RGD:1318297 6480464 MOCOS gene SNP results in decreased oxidation of Mercaptopurine CTD PMID:29935280 Mocos Rat quercetin decreases expression ISO RGD:1318297 6480464 Quercetin results in decreased expression of MOCOS mRNA CTD PMID:21632981 Mocos Rat SB 431542 multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Mocos Rat silicon dioxide decreases expression ISO RGD:1318297 6480464 Silicon Dioxide results in decreased expression of MOCOS mRNA CTD PMID:25351596 Mocos Rat silicon dioxide increases expression ISO RGD:1616767 6480464 Silicon Dioxide results in increased expression of MOCOS mRNA CTD PMID:29203145 Mocos Rat silver atom increases expression ISO RGD:1616767 6480464 Silver results in increased expression of MOCOS mRNA CTD PMID:27131904 Mocos Rat silver(0) increases expression ISO RGD:1616767 6480464 Silver results in increased expression of MOCOS mRNA CTD PMID:27131904 Mocos Rat sodium arsenite multiple interactions ISO RGD:1318297 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MOCOS more ... CTD PMID:39836092 Mocos Rat succimer multiple interactions ISO RGD:1616767 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOCOS mRNA CTD PMID:21641980 Mocos Rat sunitinib increases expression ISO RGD:1318297 6480464 Sunitinib results in increased expression of MOCOS mRNA CTD PMID:31533062 Mocos Rat temozolomide increases expression ISO RGD:1318297 6480464 Temozolomide results in increased expression of MOCOS mRNA CTD PMID:31758290 Mocos Rat tioguanine multiple interactions ISO RGD:1318297 6480464 [MOCOS gene SNP results in decreased oxidation of Mercaptopurine] which results in increased chemical synthesis more ... CTD PMID:29935280 Mocos Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MOCOS mRNA CTD PMID:33387578 Mocos Rat trichostatin A increases expression ISO RGD:1318297 6480464 trichostatin A results in increased expression of MOCOS mRNA CTD PMID:24935251 Mocos Rat triclosan increases expression ISO RGD:1318297 6480464 Triclosan results in increased expression of MOCOS mRNA CTD PMID:30510588 Mocos Rat valproic acid increases expression ISO RGD:1318297 6480464 Valproic Acid results in increased expression of MOCOS mRNA CTD PMID:23179753|PMID:24383497|PMID:26272509 Mocos Rat valproic acid multiple interactions ISO RGD:1318297 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Mocos Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MOCOS mRNA CTD PMID:23034163
(+)-catechin (ISO) (-)-epigallocatechin 3-gallate (ISO) (1->4)-beta-D-glucan (ISO) 1,2-dimethylhydrazine (ISO) 1-nitropyrene (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 3,7-dihydropurine-6-thione (ISO) 3-chloropropane-1,2-diol (EXP) 4,4'-sulfonyldiphenol (ISO) 4-hydroxynon-2-enal (ISO) 6-propyl-2-thiouracil (EXP) 6-Thiourate (ISO) 8-Br-cAMP (ISO) amphetamine (EXP) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) arsenous acid (ISO) atrazine (EXP) azathioprine (ISO) benzo[a]pyrene (ISO) Benzo[k]fluoranthene (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) bromobenzene (EXP) butan-1-ol (ISO) cadmium dichloride (ISO) cadmium sulfate (ISO) caffeine (ISO) carbamazepine (ISO) chromium(6+) (ISO) cisplatin (ISO) cobalt dichloride (EXP) copper atom (ISO) copper(0) (ISO) copper(II) sulfate (ISO) Cuprizon (EXP) cyclosporin A (ISO) diarsenic trioxide (ISO) Didecyldimethylammonium (ISO) disodium selenite (ISO) dorsomorphin (ISO) endosulfan (EXP) entinostat (ISO) epoxiconazole (ISO) etoposide (ISO) genistein (ISO) inulin (ISO) isotretinoin (ISO) lead diacetate (ISO) lucanthone (ISO) mercaptopurine (ISO) metformin (EXP) mitoxantrone (ISO) N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal (ISO) N-methyl-4-phenylpyridinium (ISO) paracetamol (EXP,ISO) pentachlorophenol (ISO) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) phenylmercury acetate (ISO) potassium chromate (ISO) purine-6-thiol (ISO) quercetin (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) succimer (ISO) sunitinib (ISO) temozolomide (ISO) tioguanine (ISO) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) valproic acid (ISO) vinclozolin (EXP)
Mocos Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 18 16,206,402 - 16,251,928 (+) NCBI GRCr8 mRatBN7.2 18 15,931,659 - 15,977,415 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 18 15,931,654 - 15,977,187 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 18 16,117,319 - 16,162,950 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 18 16,900,026 - 16,945,653 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 18 16,188,313 - 16,233,744 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 18 16,590,086 - 16,636,312 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 18 16,590,197 - 16,636,084 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 18 16,349,169 - 16,395,056 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 18 16,420,503 - 16,466,040 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 18 16,447,589 - 16,492,609 (+) NCBI Celera 18 15,859,448 - 15,904,747 (+) NCBI Celera Cytogenetic Map 18 p12 NCBI
MOCOS Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 18 36,187,497 - 36,272,157 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 18 36,187,497 - 36,272,157 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 18 33,767,460 - 33,852,120 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 18 32,021,478 - 32,102,683 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 18 32,021,479 - 32,102,682 NCBI Celera 18 30,575,346 - 30,656,592 (+) NCBI Celera Cytogenetic Map 18 q12.2 NCBI HuRef 18 30,626,379 - 30,707,547 (+) NCBI HuRef CHM1_1 18 33,694,591 - 33,775,784 (+) NCBI CHM1_1 T2T-CHM13v2.0 18 36,379,059 - 36,463,756 (+) NCBI T2T-CHM13v2.0
Mocos Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 18 24,786,538 - 24,834,634 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 18 24,786,748 - 24,834,632 (+) Ensembl GRCm39 Ensembl GRCm38 18 24,653,492 - 24,701,577 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 18 24,653,691 - 24,701,575 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 18 24,812,192 - 24,860,057 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 18 24,796,497 - 24,844,587 (+) NCBI MGSCv36 mm8 Celera 18 25,135,661 - 25,183,078 (+) NCBI Celera Cytogenetic Map 18 A2 NCBI cM Map 18 13.18 NCBI
Mocos Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955402 22,754,064 - 22,808,167 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955402 22,754,034 - 22,808,428 (+) NCBI ChiLan1.0 ChiLan1.0
MOCOS Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 17 53,583,357 - 53,667,798 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 18 39,275,899 - 39,381,547 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 18 29,440,016 - 29,542,105 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 18 32,998,527 - 33,080,053 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 18 32,998,769 - 33,080,053 (+) Ensembl panpan1.1 panPan2
MOCOS Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 7 53,950,561 - 54,002,046 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 7 53,945,436 - 54,002,252 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 7 53,373,914 - 53,427,347 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 7 53,918,314 - 53,971,999 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 7 53,913,166 - 53,972,004 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 7 53,601,974 - 53,655,234 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 7 53,625,167 - 53,678,696 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 7 53,917,631 - 53,971,177 (-) NCBI UU_Cfam_GSD_1.0
Mocos Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404944 49,728,523 - 49,778,989 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936517 9,055,805 - 9,105,357 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936517 9,059,042 - 9,105,304 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
MOCOS Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 6 119,945,052 - 120,018,097 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 6 119,945,076 - 120,018,332 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 6 112,471,601 - 112,544,699 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
MOCOS Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 18 44,570,277 - 44,627,641 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 18 44,581,987 - 44,627,557 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666050 19,026,451 - 19,088,270 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Mocos
.
Predicted Target Of
Count of predictions: 33 Count of miRNA genes: 33 Interacting mature miRNAs: 33 Transcripts: ENSRNOT00000066583 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
2301410 Bp317 Blood pressure QTL 317 0.004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 18 11944273 26548295 Rat 1358358 Sradr6 Stress Responsive Adrenal Weight QTL 6 2.49 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 18 11944299 59330563 Rat 61382 Bp46 Blood pressure QTL 46 18.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 11941791 31393320 Rat 8552968 Pigfal19 Plasma insulin-like growth factor 1 level QTL 19 11.4 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 18 1 25758124 Rat 61388 Bp2 Blood pressure QTL 2 3.23 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 18 1 35374722 Rat 1331781 Scl28 Serum cholesterol level QTL 28 3.995 blood HDL cholesterol amount (VT:0000184) serum high density lipoprotein cholesterol level (CMO:0000361) 18 11944299 24797117 Rat 6903359 Bp355 Blood pressure QTL 355 3.6 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 11944544 59796478 Rat 2313082 Bss85 Bone structure and strength QTL 85 0.8 0.0001 long bone metaphysis morphology trait (VT:0000133) tibia midshaft total cross-sectional area (CMO:0001715) 18 14951337 59951337 Rat 2312568 Glom21 Glomerulus QTL 21 2 0.005 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 18 5185858 40503530 Rat 1331766 Bp236 Blood pressure QTL 236 3.022 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 18 11944299 31359530 Rat 631264 Scl22 Serum cholesterol level QTL 22 6.2 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 18 11941791 31393320 Rat 12904680 Bw189 Body weight QTL 189 0.019 body mass (VT:0001259) body weight (CMO:0000012) 18 11944273 26548295 Rat 2293708 Bss46 Bone structure and strength QTL 46 8.8 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 18 11791518 63636873 Rat 1641910 Colcr3 Colorectal carcinoma resistance QTL 3 5.02 0.000007 intestine integrity trait (VT:0010554) poorly differentiated malignant colorectal tumor number (CMO:0002076) 18 2249477 22066430 Rat 12904693 Am20 Aortic mass QTL 20 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 18 11944273 26548295 Rat 9589153 Insul31 Insulin level QTL 31 7.15 0.05 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 18 1 42547119 Rat 1578667 Bss21 Bone structure and strength QTL 21 3.5 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 18 11791518 83218561 Rat 12904695 Kidm73 Kidney mass QTL 73 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 18 11944273 26548295 Rat 2312598 Bp340 Blood pressure QTL 340 0.05 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 1 30558703 Rat 12904689 Cm128 Cardiac mass QTL 128 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 18 11944273 26548295 Rat 12904690 Cm129 Cardiac mass QTL 129 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 18 11944273 26548295 Rat 2300180 Bmd67 Bone mineral density QTL 67 4.8 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 18 1 34291613 Rat 12904691 Cm130 Cardiac mass QTL 130 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 18 11944273 26548295 Rat 9590248 Scort10 Serum corticosterone level QTL 10 19.71 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 18 1 25758124 Rat 2299160 Iddm35 Insulin dependent diabetes mellitus QTL 35 2.79 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 18 4207941 60377792 Rat 1578661 Bss20 Bone structure and strength QTL 20 3.7 femur morphology trait (VT:0000559) femoral neck cross-sectional area (CMO:0001697) 18 11791518 83218561 Rat 1331753 Bp231 Blood pressure QTL 231 3.643 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 18 11944299 52293055 Rat 2293661 Bss50 Bone structure and strength QTL 50 4.64 0.0003 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 18 1 34291613 Rat 61375 Bp41 Blood pressure QTL 41 2.4 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 18 11944299 41122201 Rat
D18Chm6
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 18 16,208,753 - 16,208,950 (+) Marker Load Pipeline mRatBN7.2 18 15,934,010 - 15,934,209 (+) MAPPER mRatBN7.2 Rnor_6.0 18 16,592,554 - 16,592,748 NCBI Rnor6.0 Rnor_5.0 18 16,351,526 - 16,351,720 UniSTS Rnor5.0 RGSC_v3.4 18 16,422,860 - 16,423,054 UniSTS RGSC3.4 Celera 18 15,861,805 - 15,862,005 UniSTS Cytogenetic Map 18 p12 UniSTS
BE110321
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 18 15,976,997 - 15,977,148 (+) MAPPER mRatBN7.2 Rnor_6.0 18 16,635,895 - 16,636,045 NCBI Rnor6.0 Rnor_5.0 18 16,394,867 - 16,395,017 UniSTS Rnor5.0 RGSC_v3.4 18 16,465,851 - 16,466,001 UniSTS RGSC3.4 Celera 18 15,904,558 - 15,904,708 UniSTS RH 3.4 Map 18 186.0 UniSTS Cytogenetic Map 18 p12 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
111
91
90
59
25
59
6
218
97
91
45
59
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000066583 ⟹ ENSRNOP00000061024
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 18 15,931,654 - 15,977,187 (+) Ensembl Rnor_6.0 Ensembl 18 16,590,197 - 16,636,084 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093190
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 18 16,590,590 - 16,624,520 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093441 ⟹ ENSRNOP00000076247
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 18 16,590,602 - 16,609,554 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093449
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 18 16,613,591 - 16,616,947 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093641 ⟹ ENSRNOP00000076169
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 18 16,616,937 - 16,636,082 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093715 ⟹ ENSRNOP00000076171
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 18 15,931,654 - 15,977,187 (+) Ensembl Rnor_6.0 Ensembl 18 16,590,408 - 16,636,064 (+) Ensembl
RefSeq Acc Id:
NM_001395671 ⟹ NP_001382600
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 18 16,206,402 - 16,251,928 (+) NCBI mRatBN7.2 18 15,931,659 - 15,977,185 (+) NCBI
RefSeq Acc Id:
XM_017600988 ⟹ XP_017456477
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 18 16,206,727 - 16,251,786 (+) NCBI mRatBN7.2 18 15,931,659 - 15,977,415 (+) NCBI Rnor_6.0 18 16,590,107 - 16,635,984 (+) NCBI
Sequence:
GGTGCAGGAGGTCACACCAGAGCGTCCGGCTCTGAAGTTGCATAATCGCTAGGAGTTTATCAAGCAGCTCAATGGTTTCCTTTGAACCGCGGGGAGTGCAGTCGACCACAGCAGTCCAAGTGGACTTG
hide sequence
RefSeq Acc Id:
XM_063277463 ⟹ XP_063133533
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 18 16,206,724 - 16,248,666 (+) NCBI
RefSeq Acc Id:
XM_063277464 ⟹ XP_063133534
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 18 16,206,722 - 16,248,666 (+) NCBI
RefSeq Acc Id:
XR_001842027
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 18 16,206,727 - 16,251,786 (+) NCBI mRatBN7.2 18 15,931,659 - 15,977,415 (+) NCBI Rnor_6.0 18 16,590,108 - 16,635,984 (+) NCBI
Sequence:
GTGCAGGAGGTCACACCAGAGCGTCCGGCTCTGAAGTTGCATAATCGCTAGGAGTTTATCAAGC
hide sequence
RefSeq Acc Id:
XP_017456477 ⟸ XM_017600988
- Peptide Label:
isoform X3
- Sequence:
MACGATERGPEPPAFQRHPEASAPRLAHGYGLRSMSELRDQEFGRLAGTVYLDHAGATLFPQSQLTNFTKDLMENVYGNPHSQNITSKLTHDTVEQVRYRVLTHFHTTPEDYSVIFTAGSTAALRLVA
hide sequence
Ensembl Acc Id:
ENSRNOP00000076171 ⟸ ENSRNOT00000093715
Ensembl Acc Id:
ENSRNOP00000076169 ⟸ ENSRNOT00000093641
Ensembl Acc Id:
ENSRNOP00000076247 ⟸ ENSRNOT00000093441
Ensembl Acc Id:
ENSRNOP00000061024 ⟸ ENSRNOT00000066583
RefSeq Acc Id:
NP_001382600 ⟸ NM_001395671
- UniProtKB:
A0A1W2Q693 (UniProtKB/TrEMBL), A6J2K9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063133534 ⟸ XM_063277464
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_063133533 ⟸ XM_063277463
- Peptide Label:
isoform X1
RGD ID: 13700672 Promoter ID: EPDNEW_R11191 Type: initiation region Name: Mocos_1 Description: molybdenum cofactor sulfurase SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 18 16,590,590 - 16,590,650 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Mocos
molybdenum cofactor sulfurase
Mocos_predicted
molybdenum cofactor sulfurase (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-12
Mocos_predicted
molybdenum cofactor sulfurase (predicted)
Symbol and Name status set to approved
70820 APPROVED
